维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Clark Lewis L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Invasion by extremes: Population spread with variation in dispersal and reproduction显示文摘	Clark J S Lewis M Horvath L	2001	American Naturalist2001，157，：	1
2	L-DOPA disrupts activity in the nu- cleus accumbens during reversal learning in Parkinson's disease显示文摘	Cools R Lewis S J Clark L	2007	Neuropsychopharmacology2007，32，1：	1
3	Multilocular cystic renal adenocarcinoma arising in a solitary kid-ney显示文摘	Lewis R H Clark M A Dobson C L	1982	J Urol1982，127，：	1
4	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type2 diabetes显示文摘	LEWIS E J HUNSICKER L G CLARKE W R		0，，12：	1
5	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Lewis E J Hunsicker L G Clarke W R	2001	N Engl J Med2001，345，12：	1
6	Renoprotective effect of the angiotensin-receptor irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	LEWIS E J HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，：	1
7	L-DOPA disrupts acti- vity in the nucleus accumbens during reversal learning in Parkinson's disease显示文摘	Cools R Lewis SJ Clark L	2007	Neuropsychopharmacology2007，32，1：	1
8	Subspecialization of CXCR5+ T cells:B helper activity is focused in a germinal center localized subset of CXCR5+ T cells显示文摘	Kim C H Rott L S Clark Lewis I	2001	J Exp Med2001，193，12：	1
9	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabets显示文摘	LEWIS E J HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，：	1
10	Structure-activity relationships of chemokines 显示文摘	Clark Lewis L Kim K S Rajarathnam K	1995	Journal of Leukocyte Biology1995，57，：	1
11	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，：	1
12	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Lewis E J Hunsicker L G Clarke W R	2001	New Engl J Med2001，345，12：	1
13	L-DOPA disrupts activity in thenucleusaccumbens during reversal learning in Parkinson' s diseas 显示文摘	Cools R Lewis SJ Clark L	2007	Neuropsychopharmacology2007，32，1：	1
14	Invasion by extremes: population spread with variation in dispersal and reproduction显示文摘	CLARK J S LEWIS M HORVATH L	2001	American Naturalist2001，157，：	1
15	Renop rotective effect of the angiotensin 2 recep-tor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Lewis E J Hunsicker L G Clarke W R	2001	N Engl J Med2001，345，：	1
16	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to Type 2 diabetes显示文摘	Hunsicker L G Clarke W R	2001	N Engl J Med2001，345，12：	1
17	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes 显示文摘	LEWIS E J HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，12：	1
18	L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease显示文摘	Cools R Lewis SJ Clark L		0，，01：	1
19	Invasion by extremes:Population spread with variation in dispersal and reproduction显示文摘	Clark J S Lewis M Horvath L	2001	American Naturalis2001，157，5：	1
20	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	LEWIS E J HUNSICKER L G CLARKE W R	2001	N Engl J Med2001，345，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示